What Does Stochastic %K say about Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)?


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) for the period of 9-Day stands at 73.74% while the stochastic %D for the same period stands at 79.92%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) signals “Buy” while other important signals like the 20-Day Moving Average Vs. Price signals “Buy”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)’s 20-Day Bollinger Band indicates “Hold”.

About Company

Idera Pharmaceuticals, Inc. is a drug discovery and development company that is developing drug candidates to treat cancer and infectious, respiratory, and autoimmune diseases, and for use in combination with therapeutic and prophylactic vaccines. Idera’s proprietary drug candidates are designed to modulate Toll-like Receptors, the body’s first line of immune defense. Idera’s pioneering DNA chemistry expertise enables it to identify drug candidates for internal development and creates opportunities for multiple collaborative alliances.

Previous Day Activity Analysis

On the last trading day, Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) opened the session at $2.65 and after going up 0.75% closed at $2.67. The stock gained 0.02 points in the last trade.

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)’s stock fluctuated in the range of $2.55 and $2.68 during the previous active session. Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) traded with the volume of 1.03 Million with average volume of 1.02 Million. The stock has HIGH volatility on the last trading session.

Currently the Beta for the company remains at 2.15 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.16 and 68.81 respectively.

Currently the Insider Ownership of the shares of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) is at 0.4% and the shares outstanding are 148.5 Million.

Important Ratio Analysis

Some important ratios to consider here for Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) are discussed below:

Dividend yield of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The PEG ratio (Price to Earning to Growth) emits the value of 0. The Price to Sale P/S and Price to Book P/B shows the value of 24.48 and 5.34 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 5.13 and 0 correspondingly.

The Quick Ratio of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) stands at 11.1 while the Current Ratio depicts the value of 11.1.

Return on Assets ROA of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) is at -55.1% whereas, Return on Equity ROE and Return of Investment ROI of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) stand at -61.1% and -37.3% respectively.

Stock Performance Analysis

The stock performance of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) on the basis of 5 day trade show the jump of 9.88% whereas, the monthly performance of the stock shows increase of 33.5%.

The quarterly performance of the stock remained in green zone with the value of 45.11% while six month performance of the shares of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) remained bullish with the count of 17.11%.

The yearly and YTD performance of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) remained up at 44.32% and 78% respectively.